← Human Trials & Peer-Reviewed Studies

High prevalence of magnesium supplementation during pregnancy: results from the LIFE Child study.

Plain-language guide to PMID 42675291 (2026): observational study of Vitamin D, K2, Magnesium and Zinc in 1078 participants.

Key Facts

PMID
42675291
Journal
Archives of gynecology and obstetrics
Year
2026
Study type
Observational Study
Authors
Neininger MP et al. (8 authors)
DOI
10.1007/s00404-026-08522-z
Registered trial
NCT02550236

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as an observational study.

The researchers explored the association between magnesium supplementation and pregnancy duration.

Why It Was Studied

LIFE Child is registered under the trial number: NCT02550236.

Who Took Part

The study group was 1078 participants.

The age groups tagged for this paper are young adults and adults, women only.

The LIFE Child Study (Leipzig, Germany) recruited pregnant women and collected data in the 24th and 36th week of pregnancy from 2011 to 2019.

In this prospective observational cohort study (n = 1078 participants), the researchers analysed potential associations for magnesium supplementation with health-related factors using logistic regression models adjusted for age and socioeconomic status (SES).

How the Study Was Run

Using a generalised linear model, the researchers explored whether magnesium supplementation potentially affects pregnancy duration.

What Was Measured

The subject headings attached to it are Dietary Supplements, Magnesium, Premature Birth, Germany, Risk Factors and Prevalence.

Author keywords: Pregnancy, Pregnancy cohort, Premature contractions and Supplementation.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc in 1078 participants.

With several hundred people or more, it is a fairly large study for this kind of research.

The abstract goes on to report its results in about 8 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2026 (Archives of gynecology and obstetrics), a journal based in Germany.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.